HK Stock Market Move | ZYLOXTB (02190) rose by over 6% in the afternoon, with annual net profit increasing by over 1.4 times. The company further acquired a stake in Germany's Optimed.

ZYLOXTB (02190) rose more than 6% in the afternoon, with a 5.17% increase as of the time of press release, reaching 21.96 Hong Kong dollars, with a trading volume of 14.89 million Hong Kong dollars. On the news front, ZYLOXTB released its annual performance, with annual operating income of 1.057 billion RMB, a year-on-year increase of 35.1%; net profit surpassed 244 million RMB, a sharp increase of 143.7% year-on-year. The performance growth was mainly benefited from the continuous increase in sales of core products, accelerated expansion of international business, and steady improvement in operational efficiency. In addition, ZYLOXTB announced the exercise of options to acquire 11% of the shares of Optimed Holding, and will acquire the remaining 40% of the shares to hold full ownership by the first half of 2028, with a total estimated cost of up to 41.17 million euros (approximately 326 million RMB). Information shows that Optimed is a German medical technology company, focusing on the research, development, production, and global sales of minimally invasive vascular intervention and urological intervention medical devices.